Agios Pharmaceuticals Inc

AGIONASDAQ · USD
29.68USD-0.21 (-0.71%)
235

Agios Pharmaceuticals Inc (AGIO) Option Chain

Agios Pharmaceuticals Inc trades at $29.68, down 0.71%, with an IV Rank of 1.59%. This is low versus the past year, and the company carries a market cap of $1,788M in the Biotechnology industry. On the Nov 20, 2026 chain, the at the money $30.00 strike shows calls at $0.35 / $0.75 and puts at $0.60 / $0.90, both carrying about $0.49 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $30.00 calls, at 2 contracts, and the $30.00 puts, at 69, as of Nov 17, 2026.

Read more

Tracking the AGIO option chain helps you see every strike and expiry on Agios Pharmaceuticals Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AGIO options activity at a glance. Use our scanner to monitor the AGIO option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AGIO stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where AGIO options are being actively traded, and where they are not.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0000-0.039.687.5011.8020.00-33.09—1.550.001.55013100.00
0.00100.077.185.009.5022.50-24.72—0.750.000.7504100.00
0.001000.324.683.506.5025.00-16.36—0.750.000.750392100.00
54.2345620.550.000.350.7530.00+0.370.600.900.320.436956545.77
100.002,00000.750.00—0.7535.00+17.103.007.505.32-0.070440.00

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank1.59% Low
  • Market cap (M$)1,788
  • 52 weeks high-35.02%
  • 52 weeks low34.40%
  • Analyst recommendationStrong Buy
    1.44
  • Target price$47.00
    52.90% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2027-02-11
  • P/E—
  • Future P/E—
  • EPS (ttm)-6.32
  • EPS growth next 5 years41.61%

As of Nov 17, 2026